Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice
about
Molecular processes that handle -- and mishandle -- dietary lipidsSyndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in miceArterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeysGlycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulationCardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complicationsA computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolismInsulin-dependent diabetes mellitus in mice does not alter liver heparan sulfateRole of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice.Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors.Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteinsLipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice.Hyperglycemia impairs atherosclerosis regression in mice.Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathwayLiver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studiesSyndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.The regulation of ApoB metabolism by insulin.Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.Age-dependent alteration of intraocular soluble heparan sulfate levels and its implications for proliferative diabetic retinopathyChylomicron and palmitate metabolism by perfused hearts from diabetic mice.Role of lipids in the early developmental stages of experimental immune diabetes induced by multiple low-dose streptozotocin.Hepatocyte-derived ApoE is more effective than non-hepatocyte-derived ApoE in remnant lipoprotein clearance.Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance.Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: A long-term follow-up study
P2860
Q24642118-2298B0A1-BD46-4C79-AE31-1AC28B3CB435Q24647376-BE660696-FFE2-4089-B76C-A9AFC2A142F7Q24792393-5850480F-D7A5-4C8D-9644-B2B053AC2563Q26766645-F07624A1-60B1-4AD5-BDEE-C0CC8ED6FA3BQ27009400-E482613F-5DAA-4190-91DA-255C55CEAF4DQ28213716-51CC7F25-696D-4C31-9FBA-8CBB0449FE57Q28538300-98424E03-4F0B-4458-AF7A-71B4F7A433CAQ33541795-2F464C6E-5C7C-4C30-8ECC-EC2856CC07F5Q33869288-913ED633-1140-4264-A246-5A938E9612B8Q34114308-6918E806-E3E8-4AF5-A679-EE96630F2720Q34176669-B7FC5A33-F3F0-4279-83F7-780FB63DBA6CQ34348377-6A715A5A-26FD-4313-8317-050540465656Q34734402-C36BF13E-B191-4DEB-AAE2-645044EF5202Q35013804-9B88F25D-4CF6-40E9-9E40-93DED2704D4FQ35070156-F948C184-F81B-4D9F-BCD8-59431F91B155Q35250965-E52E52E5-2BEC-46F6-A479-0F8475CB8AE7Q35631767-A7FC739B-2F1C-4369-BF00-90B0FB64421EQ35754362-2E7F5DE4-93AF-47AD-991B-C03DC8C0E07AQ37130793-7E10DB09-FE36-4ECD-8490-9A6B5602BB05Q38110665-13E03E36-C36F-430C-83D5-FE2E78141413Q39781531-54F8A22B-A594-44A9-910B-852F478C532AQ41345085-CD602906-D9A3-4218-A1D1-DAA801A348A0Q44191957-F46B0522-0C13-44D4-81D7-ED931E5B40C0Q45259197-38A06111-C396-4F8E-9972-1893894BA64FQ46906549-D0796C46-5870-4B6E-B415-1A696EBB9144Q51457652-5116661B-DDAD-4FA2-8885-96692BD70267Q58493372-A3F38274-D1ED-4087-A289-68EDBE569DA4
P2860
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delayed catabolism of apoB-48 ...... an production in diabetic mice
@en
Delayed catabolism of apoB-48 ...... n production in diabetic mice.
@nl
type
label
Delayed catabolism of apoB-48 ...... an production in diabetic mice
@en
Delayed catabolism of apoB-48 ...... n production in diabetic mice.
@nl
prefLabel
Delayed catabolism of apoB-48 ...... an production in diabetic mice
@en
Delayed catabolism of apoB-48 ...... n production in diabetic mice.
@nl
P2093
P2860
P356
P1476
Delayed catabolism of apoB-48 ...... an production in diabetic mice
@en
P2093
I J Goldberg
N S Shachter
R Ramakrishnan
P2860
P304
P356
10.1172/JCI8283
P407
P577
2000-06-01T00:00:00Z